In-vitro antifungal activity of resorcinol against human fungal pathogen Candida albicans (original) (raw)
Pathogenicity and drug resistance in Candida albicans and other yeast species
Rajendra Prasad
Acta Microbiologica et Immunologica Hungarica, 2007
View PDFchevron_right
Antifungal Activity of Resveratrol Derivatives against Candida Species
Licence pro cosmétologie Tours
View PDFchevron_right
Inhibitory Effect of Resveratrol on <i>Candida albicans</i> Biofilm Formation
Kazuyuki Ishihara
The Bulletin of Tokyo Dental College, 2021
View PDFchevron_right
Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors
Dominique Sanglard
Antimicrobial agents and …, 1996
View PDFchevron_right
Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents
Allan Kardec Barros
View PDFchevron_right
Candida Infections, Causes, Targets, and Resistance Mechanisms: Traditional and Alternative Antifungal Agents
Dario Leonardi
BioMed Research International, 2013
View PDFchevron_right
In vivo and in vitro activity of a bis-arylidenecyclo-alkanone against fluconazole-susceptible and resistant isolates of Candida albicans
Nivea Pereira De Sa
Journal of global antimicrobial resistance, 2018
View PDFchevron_right
An Overview on Antifungal Drug Therapy
Atish Velhal
Asian journal of pharmaceutical research and development, 2023
View PDFchevron_right
Propargyl-Linked Antifolates are Dual Inhibitors of Candida albicans and Candida glabrata
Kishore Viswanathan
Journal of Medicinal Chemistry, 2014
View PDFchevron_right
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Frank Odds, Dominique Sanglard
The Lancet. Infectious diseases, 2002
View PDFchevron_right
Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans
Jinhui Cui
Virulence, 2015
View PDFchevron_right
Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicans
Letizia Angiolella
Antimicrobial Agents and Chemotherapy, 2008
View PDFchevron_right
Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast
Karl Kuchler
International Journal of Antimicrobial Agents, 2003
View PDFchevron_right
Increase of Virulence and Its Phenotypic Traits in Drug-Resistant Strains of Candida albicans
Antonio Cassone, Letizia Angiolella
Antimicrobial Agents and Chemotherapy, 2008
View PDFchevron_right
in vitro Activity of Seven Antifungals against Different Clinical Candida Species
Sadegh Nouripour-Sisakht
Journal of clinical care and skills, 2021
View PDFchevron_right
Propargyl-Linked Antifolates are Dual Inhibitors of Candida albicans and Candida glabrata
Kishore Viswanathan
Journal of Medicinal Chemistry, 2014
View PDFchevron_right
Global Clinical Case Studies in Candida species: A Review
Dr. Vijay Karuppiah, Dhandayuthapani Nisha
Asian Journal of Research in Biosciences, 2024
View PDFchevron_right
In Vitro and In Vivo Activity of a Novel Antifungal Small Molecule against Candida Infections
Sarah Wong
PLoS ONE, 2014
View PDFchevron_right
Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans
Mahmoud Ghannoum
Journal of Antimicrobial Chemotherapy, 2003
View PDFchevron_right
Beauvericin counteracted multi-drug resistant Candida albicans by blocking ABC transporters
Richard Cannon
Synthetic and Systems Biotechnology
View PDFchevron_right
International Journal of Pharma and Bio Sciences ISSN 0975-6299 STUDY OF PREVALENCE AND ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA
Ashish J
View PDFchevron_right
Substrates and modulators of the multidrug transporter Cdr1p of Candida albicans in antifungal extracts of medicinal plants
Silva Mulhovo
Mycoses, 2010
View PDFchevron_right
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile
Dellanda Firdauzi Ulwi
View PDFchevron_right
Molecular analysis and in vitro susceptibility profiling of some clinically important Candida spp. to the common antifungal drugs
ahmed medhat
African Journal of Microbiology Research, 2012
View PDFchevron_right
Total Protein Profile and Drug Resistance in Candida albicans Isolated from Clinical Samples
Kamal Uddin Zaidi
Molecular Biology International, 2016
View PDFchevron_right
In vitro Investigation of Antifungal Activities of Phenotypic Variation Candida albicans Strains against Fluconazole, Itraconazole and Voriconazole
Nuri Kiraz
Nippon Ishinkin Gakkai Zasshi, 2005
View PDFchevron_right
Growth inhibition and ultrastructural alterations induced by Δ24 (25)-sterol methyltransferase inhibitors in Candida spp. isolates, including non-albicans …
Kelly Ishida
BMC …, 2009
View PDFchevron_right
Growth inhibition and ultrastructural alterations induced by Δ24(25)-sterol methyltransferase inhibitors in Candida spp. isolates, including non-albicans organisms
Juliany Rodrigues
BMC Microbiology, 2009
View PDFchevron_right